Skip to Main Content

Paper Details

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Nat Immunol
51
2022
Author NameAffiliation
Samuel S FreemanBroad Institute of MIT and Harvard
Samuel S FreemanMassachusetts General Hospital
Samuel S FreemanCenter for Cancer Research, Massachusetts General Hospital
Samuel S FreemanBroad Institute of MIT and Harvard
Samuel S FreemanCenter for Cancer Research, Massachusetts General Hospital
Samuel S FreemanMassachusetts General Hospital
David E RootBroad Institute of MIT and Harvard
David E RootBroad Institute of MIT and Harvard
John G DoenchBroad Institute of MIT and Harvard
Nir HacohenBroad Institute of MIT and Harvard
Nir HacohenCenter for Cancer Research, Massachusetts General Hospital
Nir HacohenMassachusetts General Hospital
Nir HacohenBroad Institute of MIT and Harvard
Nir HacohenCenter for Cancer Research, Massachusetts General Hospital
Nir HacohenMassachusetts General Hospital
  • 1 - 15

Datasets

Release 1.2